Elevated Creatine Kinase as a Marker for Aggressive GI Malignancy
Ramya Vasireddy1, Joseph Atarere1, Jeffrey Iding2
1Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, USA.
Summary
This case study discusses a rare Klatskin tumor (perihilar cholangiocarcinoma) in a patient with significant creatine kinase (CK) elevation. The findings highlight challenges in diagnosing and managing aggressive biliary malignancies.
Area of Science:
- Gastroenterology and Hepatology
- Oncology
Background:
- Klatskin tumor, a rare and aggressive biliary malignancy, presents a poor prognosis.
- Management is often challenging due to rarity and patient comorbidities.
More Related Videos
07:21Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
2.7K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.8K
